Patients receiving stem cell transplantation with specialized needs regarding antithrombotic therapy can fall into two basic groups: those who are on pre-transplant therapy and those who develop thrombosis during the course of the procedure. See Table 11.1 for a summary of management guidelines.
KeywordsAtrial Fibrillation Antiplatelet Therapy Antithrombotic Therapy Inferior Vena Cava Filter CHADS2 Score
- ACCP Guidelines. (2008, Jun). Antithrombotic and thrombolytic therapy, 8th ed. Chest 133(Suppl), 67S–968S.Google Scholar
- Grines, C.L., Bonow, R.O., Casey, D.E. Jr, Gardner, T.J., Lockhart, P.B., Moliterno, D.J., et al. (2007). Prevention of premature discontinuation of dual antiplatelet therapy in patients with coronary artery stents: A science advisory from the American Heart Association, American College of Cardiology, Society for Cardiovascular Angiography and Interventions, American College of Surgeons, and American Dental Association, with representation from the American College of Physicians. Circulation, 115:813–818.Google Scholar